Celadon Pharmaceuticals Plc (LON:CEL – Get Free Report) shares dropped 27.6% on Tuesday . The stock traded as low as GBX 5 ($0.06) and last traded at GBX 10.87 ($0.14). Approximately 788,720 shares changed hands during mid-day trading, an increase of 216% from the average daily volume of 249,443 shares. The stock had previously closed at GBX 15 ($0.19).
Celadon Pharmaceuticals Stock Up 30.0 %
The firm has a market cap of £7.97 million, a price-to-earnings ratio of -1.63 and a beta of -0.26. The company has a debt-to-equity ratio of 196.67, a quick ratio of 6.97 and a current ratio of 1.92. The business’s 50-day moving average is GBX 18.25 and its 200-day moving average is GBX 22.56.
About Celadon Pharmaceuticals
Celadon Pharmaceuticals Plc is a UK-based pharmaceutical company focused on the development, production and sale of breakthrough cannabis-based medicines. Its primary focus is on improving quality of life for chronic pain sufferers, as well as exploring the potential of cannabis-based medicines for other conditions such as autism.
Read More
- Five stocks we like better than Celadon Pharmaceuticals
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Super Micro Stock: $7.2M Call Options Signal Big Upside Potential
- How to Read Stock Charts for Beginners
- Top 3 Buy-and-Hold Stocks for 2025: Long-Term Winners to Watch
- Health Care Stocks Explained: Why You Might Want to Invest
- D-Wave Stock: Is Quantum Blockchain the Next Big Catalyst?
Receive News & Ratings for Celadon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celadon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
